CSG H1 2026 Results: Continued Strong Growth Across Core Markets; Position Developed in Advanced Technologies; Leadership Team Strengthened for Global Scale

CSG reaffirmed FY 2026 guidance after H1 2026 results: revenue rose 17.2% YoY to €3,251m and Operating EBIT increased 12.7% YoY to €784m (24.1% margin). The company reported higher cash burn from working capital, with pre-tax operating cash flow of (€411)m and net working capital at 40.1% of LTM revenue (cash unwind expected in H2, mainly Q4); net debt was €2,914m with net debt/EBITDA of 1.6x but FY year-end guidance maintained at <1.3x. Outlook remains constructive with FY 2026 revenue guided at €7.4–€7.6bn and Operating EBIT margin of ~24–25%, alongside backlog/pipeline visibility up to €46bn (backlog €17bn; pipeline €29bn).

Analysis

The important read-through is not headline growth; it is that the defense winners are separating on supply-chain control and localization. Groups that own energetics, fuzes, and final assembly can turn framework demand into price and margin, while asset-light peers will increasingly have to finance inventory, tolerate longer lead times, or subcontract at lower economics. That is a medium-term positive for integrated land/munitions platforms and a quiet negative for competitors that still rely on third-party inputs.

The cash flow profile is the main near-term check on the story. If the working-capital unwind slips beyond Q4, leverage will stay higher for longer and the market will start treating the growth as balance-sheet-funded rather than self-financing, which would compress multiples even if revenue holds up. The US expansion and drone propulsion initiatives are real strategic options, but they are mostly 2027-2029 optionality; they should not be capitalized as near-term EPS drivers yet.

Contrarian view: the market may be underestimating how much of the margin expansion is tied to a temporary inventory build and overestimating how quickly new capacity converts into free cash flow. That said, the secular demand signal is still strong, and the best expression is to own the names with the most direct exposure to European artillery/ammo replenishment and the clearest local-production advantage, rather than broad primes where this print is only a weak read-through.

Key Decisions for Investors

• Buy RNMBY on any 3-5% post-event pullback; 3-6 month horizon. Best relative exposure to the European munitions and land-systems buildout, with the cleanest operating leverage to localized capacity.
• Pair trade: long RNMBY / short BAESY for 1-3 months if the sector rallies on defense headlines. Thesis: RNMBY has more direct sensitivity to artillery/ammo capacity conversion; BAESY is more exposed to slower-moving platform mix and less immediate margin re-rate.
• Avoid chasing NOC and RTX on the drone/air-defense JV headlines; treat those as 2027+ option value, not next-quarter earnings. Reassess only if there is disclosed volume, backlog, or contracted cash economics.
• Set a hard alert on year-end leverage and working-capital unwind. If net debt/EBITDA does not get back toward the stated sub-1.3x path by Q4, fade the growth premium and expect multiple compression.